Your selection basket is empty.
Define a selection of ETFs which you would like to compare.
Add an ETF by clicking "Compare" on an ETF profile or by checkmarking an ETF in the ETF search.
| Market capitalisation, EUR | 93,195 m |
| EPS, EUR | - |
| P/B ratio | 1.3 |
| P/E ratio | 18.7 |
| Dividend yield | 3.56% |
| Revenue, EUR | 43,643 m |
| Net income, EUR | 4,941 m |
| Profit margin | 11.32% |
| ETF | Weight | Investment focus | Fund size (in m EUR) |
|---|---|---|---|
| First Trust Value Line® Dividend Index UCITS ETF Acc | 0.45% | Equity United States Dividend | 6 |
| iShares Nasdaq US Biotechnology UCITS ETF USD (Dist) | 0.95% | Equity United States Health Care Biotech | 46 |
| iShares Nasdaq US Biotechnology UCITS ETF | 0.95% | Equity United States Health Care Biotech | 710 |
| Invesco Nasdaq Next Generation 100 UCITS ETF Acc | 0.58% | Equity United States | 39 |
| YTD | -8.79% |
| 1 month | -5.84% |
| 3 months | -5.13% |
| 6 months | -13.53% |
| 1 year | -16.16% |
| 3 years | - |
| 5 years | - |
| Since inception (MAX) | -13.56% |
| 2025 | -6.87% |
| 2024 | -0.74% |
| 2023 | - |
| 2022 | - |
| Volatility 1 year | 24.96% |
| Volatility 3 years | - |
| Volatility 5 years | - |
| Return per risk 1 year | -0.65 |
| Return per risk 3 years | - |
| Return per risk 5 years | - |
| Maximum drawdown 1 year | -20.85% |
| Maximum drawdown 3 years | - |
| Maximum drawdown 5 years | - |
| Maximum drawdown since inception | -31.94% |